Ligufalimab (Anti-CD47)

Ligufalimab (Anti-CD47) is a humanized immunoglobulin G4 (IgG4) monoclonal antibody targeting leukocyte surface antigen CD47, with potential immune checkpoint inhibitory and antineoplastic activities. MW : 144.58 KD.
Supplier Selleck Chemicals
Product # A2825
Sku # A2825-1mg
Pricing 1mg, $539.00
Feedback